Testing effectiveness (Phase 2)Active Not RecruitingNCT05176002
What this trial is testing
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
Who this might be right for
Esophageal NeoplasmImmunotherapyRadiotherapy
Fujian Medical University Union Hospital 25